Bernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future growth for the Indian healthcare sector. Key drivers include AI-led innovation, incremental advancements in niche areas, and improved quality culture. Attractive valuations also support this positive outlook for the industry.
Market Samachar is a news aggregator. This article was originally published by Stocks-Markets-Economic Times. Tap the button above to read the full story on their site.
Trade NSE stocks with virtual coins. Build a portfolio, climb the leaderboard — zero real money.
1,500+ Indian market quiz questions. Earn coins per correct answer, climb leagues, build streaks.
Live gainers · losers · FII/DII · MTF · News Buzz. The complete Indian market dashboard.
Swipe BULL or BEAR on today's news. Earn +5 coins per swipe, +20 bonus when you're right.